Ipca Laboratories Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2025.

Powered by Capital Market - Live News

Ipca Laboratories Ltd gained for a fifth straight session today. The stock is quoting at Rs 1703.45, up 0.49% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.49% on the day, quoting at 23759.900390625. The Sensex is at 78574.27, up 0.56%. Ipca Laboratories Ltd has gained around 11.12% in last one month.

Meanwhile, Nifty Pharma index of which Ipca Laboratories Ltd is a constituent, has gained around 4.35% in last one month and is currently quoting at 23412.25, up 0.06% on the day. The volume in the stock stood at 4.6 lakh shares today, compared to the daily average of 6.54 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 1701, up 0.55% on the day. Ipca Laboratories Ltd is up 53% in last one year as compared to a 9.67% jump in NIFTY and a 35.62% jump in the Nifty Pharma index.

The PE of the stock is 61.59 based on TTM earnings ending September 24.

Powered by Capital Market - Live News

Ipca Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs 1656.9, up 1.49% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.04% on the day, quoting at 23803.900390625. The Sensex is at 78735.73, up 0.05%. Ipca Laboratories Ltd has added around 8.08% in last one month.

Meanwhile, Nifty Pharma index of which Ipca Laboratories Ltd is a constituent, has added around 3.31% in last one month and is currently quoting at 23008.35, up 0.8% on the day. The volume in the stock stood at 5.8 lakh shares today, compared to the daily average of 6.35 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 1662.5, up 1.15% on the day. Ipca Laboratories Ltd is up 48.02% in last one year as compared to a 9.48% gain in NIFTY and a 37.57% gain in the Nifty Pharma index.

The PE of the stock is 59.29 based on TTM earnings ending September 24.

Powered by Capital Market - Live News

Ipca Laboratories has received necessary approval for voluntary closure of its wholly owned subsidiary Ipca Pharmaceuticals SA de CV, Mexico.

This wholly owned subsidiary incorporated in Mexico was not doing any business for the past several years. Voluntary closure of this wholly owned subsidiary will not have any impact on Company's business or financials.

Powered by Capital Market - Live News